# CaffeinICU Study - A Study on Oral Caffeine in ICU Patients With Coma

> **NCT05232734** · PHASE2 · SUSPENDED · sponsor: **Singapore General Hospital** · enrollment: 10 (actual)

## Conditions studied

- Depressed GCS

## Interventions

- **DRUG:** Caffeine Citrate 20 MG/ML Oral Solution

## Key facts

- **NCT ID:** NCT05232734
- **Lead sponsor:** Singapore General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-11-24
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Study amendment done in view of low recruitment numbers. Updated HSA approved study protocol awaiting IRB approval before study re-commences
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05232734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05232734, "CaffeinICU Study - A Study on Oral Caffeine in ICU Patients With Coma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05232734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*